ArticleRedox biology2026
The ribonuclease ZC3H12A stabilizes BRCA1 mRNA in DNA damage response.
Article in Redox biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ZC3H12A is an endoribonuclease that destabilizes target transcripts by recognizing stem-loop structures containing a pyrimidine-purine-pyrimidine loop. Here, we identify ZC3H12A as a constitutive stabilizer of BRCA1 mRNA that supports DNA repair capacity. Under basal conditions, depletion of ZC3H12A shortens the half-life of BRCA1 mRNA, reduces its ribosomal loading and lowers BRCA1 protein levels, whereas overexpression has the opposite effect. ZC3H12A binds to the BRCA1 transcript via its PilT N-terminal (PIN) and CCCH-type zinc finger (ZF) domains; enhanced crosslinking and immunoprecipitation (eCLIP) narrows the bound sequence to defined intervals that lie outside the canonical stem-loop element through which ZC3H12A recognizes inflammatory transcripts. Moreover, ionizing radiation induces TBK1-dependent phosphorylation of ZC3H12A at Ser386, accompanied by the export of ZC3H12A from the nucleus and its redistribution to cytoplasmic ribosomes. Phosphorylated ZC3H12A occupies a broader region of BRCA1 transcript without promoting its degradation, thereby further prolonging its half-life and increasing its ribosomal loading. As a result, under genotoxic stress, the supply of BRCA1 increases, thereby supporting RAD51 recruitment and homologous recombination repair. These findings identify ZC3H12A as a post-transcriptional regulator of BRCA1 mRNA and show how Ser386 phosphorylation amplifies a protective function that is already present before damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.